Return to Article Details
IMPACT OF A RESTRICTIVE DRUG ACCESS PROGRAM ON THE RISK OF CARDIOVASCULAR ENCOUNTERS IN CHILDREN EXPOSED TO ADHD MEDICATIONS
Download
Download PDF